SCHEMBL10290337

SCHEMBL10290337

CCCCCCC(CC)C(=O)OCc1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
PTGS1 P23219 1/20 0.47
SLC6A2 P23975 1/20 0.47
CNR2 P34972 1/20 0.46
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 1/20 0.45
LPAR3 Q9UBY5 1/20 0.43
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
HPGD P15428 2/20 0.42
HSD17B10 Q99714 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
TSHR P16473 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10291289 0.85 PGR (0.46) PGRADORA3PTGS1SLC6A2CNR2
SCHEMBL12352573 0.84 PGR (0.52) PGRADORA3PTGS1SLC6A2CNR2
SCHEMBL29650273 0.80 CETP (0.51) CNR2PRSS1PRSS2PRSS3HPGD
SCHEMBL27729776 0.80 CETP (0.51) CNR2PRSS1PRSS2PRSS3HPGD
SCHEMBL29650322 0.80 CETP (0.51) CNR2PRSS1PRSS2PRSS3HPGD
SCHEMBL28547677 0.80 CETP (0.51) CNR2PRSS1PRSS2PRSS3HPGD
SCHEMBL27851258 0.80 CETP (0.51) CNR2PRSS1PRSS2PRSS3HPGD
SCHEMBL29650278 0.79 CETP (0.50) CNR2PRSS1PRSS2PRSS3HPGD
Hydrochloric Acid SCHEMBL29160910 0.79 CETP (0.50) CNR2PRSS1PRSS2PRSS3HPGD
Hydrochloric Acid SCHEMBL29160806 0.79 CETP (0.50) CNR2PRSS1PRSS2PRSS3HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120041190-A1 MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041190-A1 MACROCYCLES AS FACTOR XIA INHIBITORS TFPI, TFPI2, F11 PGR 3070/4885ADORA3 4423/4885PTGS1 1191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.